Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Modulation of mGlu5 receptor activity may provide benefit in incontinence and overactive bladder

Sep. 4, 2007

Plans delayed for phase III study of bremelanotide for ED

Sep. 3, 2007

Recent Takeda patent reports novel tachykinin NK1 antagonists

Sep. 3, 2007

Orexo's treatment for nocturia/incontinence enters phase I

Aug. 31, 2007

BioLineRx Inlicenses acute kidney injury treatment

Aug. 30, 2007

SVT-40776 increases voiding volume in healthy postmenopausal women

Aug. 30, 2007

New serotonin receptor antagonist for the treatment of incontinence described by Recordati

Aug. 29, 2007

Effect of KRP-204 on C-fiber urethral afferent nerves suggests benefit in urgency

Aug. 29, 2007

Pooled data show dose-related efficacy of fesoterodine in overactive bladder

Aug. 29, 2007

Experimental evidence points to besipirdine efficacy in urinary incontinence

Aug. 28, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...